These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12851530)

  • 1. Hemoglobin induces the production and release of matrix metalloproteinase-9 from human malignant cells.
    Siddiqui FA; Siddiqui TF; Francis JL
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):449-55. PubMed ID: 12851530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin enhances tissue factor expression on human malignant cells.
    Siddiqui FA; Amirkhosravi A; Amaya M; Meyer T; Biggerstaff J; Desai H; Francis JL
    Blood Coagul Fibrinolysis; 2001 Apr; 12(3):171-7. PubMed ID: 11414630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin induces the expression and secretion of vascular endothelial growth factor from human malignant cells.
    Siddiqui FA; Desai H; Siddiqui TF; Francis JL
    Hematol J; 2002; 3(5):264-70. PubMed ID: 12391545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic fibroblast growth factor induces the expression of matrix metalloproteinase-3 in human periodontal ligament cells through the MEK2 mitogen-activated protein kinase pathway.
    Shimazu A; Morishita M
    J Periodontal Res; 2003 Apr; 38(2):122-9. PubMed ID: 12608905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways.
    Kadri Z; Petitfrère E; Boudot C; Freyssinier JM; Fichelson S; Mayeux P; Emonard H; Hornebeck W; Haye B; Billat C
    Cell Growth Differ; 2000 Nov; 11(11):573-80. PubMed ID: 11095246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin binds melanoma cell tissue factor and enhances its procoagulant activity.
    Siddiqui FA; Francis JL
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):173-80. PubMed ID: 11943929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells.
    Denkert C; Koch I; Berger S; Köbel M; Siegert A; Hauptmann S
    Cancer Lett; 2003 May; 195(1):101-9. PubMed ID: 12767518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: the role of MAP kinase signaling pathways.
    Lee SJ; Park SS; Cho YH; Park K; Kim EJ; Jung KH; Kim SK; Kim WJ; Moon SK
    Oncol Rep; 2008 Apr; 19(4):1007-13. PubMed ID: 18357389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells.
    Ge X; Fu YM; Meadows GG
    Cancer Lett; 2002 May; 179(2):133-40. PubMed ID: 11888667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases.
    Yao JS; Chen Y; Zhai W; Xu K; Young WL; Yang GY
    Circ Res; 2004 Aug; 95(4):364-71. PubMed ID: 15256478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells.
    Reddy KB; Krueger JS; Kondapaka SB; Diglio CA
    Int J Cancer; 1999 Jul; 82(2):268-73. PubMed ID: 10389762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
    Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
    Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors.
    Liu Z; Klominek J
    Thorax; 2003 Mar; 58(3):198-203. PubMed ID: 12612292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways.
    Eberhardt W; Huwiler A; Beck KF; Walpen S; Pfeilschifter J
    J Immunol; 2000 Nov; 165(10):5788-97. PubMed ID: 11067938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis.
    Baek JH; Jang JE; Kang CM; Chung HY; Kim ND; Kim KW
    Oncogene; 2000 Sep; 19(40):4621-31. PubMed ID: 11030151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
    Adya R; Tan BK; Punn A; Chen J; Randeva HS
    Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells.
    Yao J; Xiong S; Klos K; Nguyen N; Grijalva R; Li P; Yu D
    Oncogene; 2001 Dec; 20(56):8066-74. PubMed ID: 11781819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p38 MAP kinase mediates transforming-growth factor-β1-induced upregulation of matrix metalloproteinase-9 but not -2 in human brain pericytes.
    Takahashi Y; Maki T; Liang AC; Itoh K; Lok J; Osumi N; Arai K
    Brain Res; 2014 Dec; 1593():1-8. PubMed ID: 25451097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.